By otakuyassine3@gmail.com 
Foster & Motley Inc. lessened its stake in shares of Encompass Health Co. (NYSE:EHC – Free Report) by 1.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,773 shares of the company’s stock after selling 177 shares during the quarter. Foster & Motley Inc.’s holdings in Encompass Health were worth $1,549,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of EHC. State Street Corp lifted its stake in shares of Encompass Health by 0.7% in the third quarter. State Street Corp now owns 3,025,769 shares of the company’s stock worth $292,410,000 after acquiring an additional 21,329 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Encompass Health by 1.2% in the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after acquiring an additional 20,547 shares in the last quarter. Copeland Capital Management LLC lifted its stake in shares of Encompass Health by 1.0% in the third quarter. Copeland Capital Management LLC now owns 1,284,550 shares of the company’s stock worth $124,139,000 after acquiring an additional 12,433 shares in the last quarter. Point72 Asset Management L.P. lifted its stake in shares of Encompass Health by 2,458.5% in the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock worth $83,990,000 after acquiring an additional 835,135 shares in the last quarter. Finally, Thrivent Financial for Lutherans lifted its stake in shares of Encompass Health by 26.0% in the third quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock worth $73,494,000 after acquiring an additional 156,938 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.
Encompass Health Stock Up 2.9 %
Shares of Encompass Health stock opened at $98.38 on Friday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The business’s 50 day simple moving average is $96.56 and its 200-day simple moving average is $94.60. The stock has a market capitalization of $9.91 billion, a price-to-earnings ratio of 23.76, a PEG ratio of 1.13 and a beta of 0.89. Encompass Health Co. has a twelve month low of $70.83 and a twelve month high of $104.55.
Encompass Health (NYSE:EHC – Get Free Report) last posted its earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same period last year, the firm earned $0.86 EPS. The firm’s revenue was up 11.9% compared to the same quarter last year. Equities research analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on EHC shares. KeyCorp increased their target price on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Royal Bank of Canada increased their target price on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Truist Financial reaffirmed a “buy” rating and set a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Finally, Barclays increased their target price on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $107.11.
Encompass Health Profile
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Further Reading
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Encompass Health and related companies with MarketBeat.com’s FREE daily email newsletter.